Form 4 for CSTL CASTLE BIOSCIENCES INC
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-09 · accession 0001447362-22-000194 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-13 | 2022-12-10 | CSTL | Oelschlager Kristen M | COO | F - Tax | $22.32 | -2,334 | 111.7K | -2% | -$52.1K |
| DM | 2022-12-13 | 2022-12-10 | CSTL | Oelschlager Kristen M | COO | M - OptEx | $0.00 | +7,920 | 113.6K | +7% | $0 |
| D | 2022-12-13 | 2022-12-09 | CSTL | Oelschlager Kristen M | COO | A - Grant | $0.00 | +63.8K | 63.8K | New | $0 |
| DM | 2022-12-13 | 2022-12-10 | CSTL | Oelschlager Kristen M | COO | M - OptEx | $0.00 | -7,920 | 3,500 | -69% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-10 | F | D | 516 | $22.32 | 107,384 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-10 | M | A | 1,750 | $0.00 | 107,900 | D | — | — | (F1) Includes 277 shares acquired on August 31, 2022, under Castle Biosciences' employee stock purchase plan. |
| 3 | Common | Common Stock | 2022-12-10 | F | D | 1,818 | $22.32 | 111,736 | D | — | — | |
| 4 | Common | Common Stock | 2022-12-10 | M | A | 6,170 | $0.00 | 113,554 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2022-12-09 | A | A | 63,844 | $0.00 | 63,844 | D | — · — to — | 63,844 Common Stock | (F2) Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. (F3) The RSU's vest in four equal annual installments beginning on December 9, 2023. |
| 6 | Derivative | Restricted Stock Units | 2022-12-10 | M | D | 6,170 | $0.00 | 18,509 | D | — · — to — | 6,170 Common Stock | (F2) Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. (F5) On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022. |
| 7 | Derivative | Restricted Stock Units | 2022-12-10 | M | D | 1,750 | $0.00 | 3,500 | D | — · — to — | 1,750 Common Stock | (F2) Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. (F4) On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021. |